Baxter-Holland, M. ., & Dass, C. . (2018). Doxorubicin, mesenchymal stem cell toxicity and antitumour activity: implications for clinical use. The Journal of Pharmacy and Pharmacology. https://doi.org/10.1111/jphp.12869 (Original work published 2018)